HORIZON EUROPE | FEBRUARY 2022 CALLS

Due to our expertise and extensive knowledge in the regulatory field for innovative therapies and medical device development, Asphalion can provide with a sound value to Consortia planning to apply.

Due to our expertise and extensive knowledge in the regulatory field for innovative therapies and medical device development, Asphalion can provide with a sound value to Consortia planning to apply.
December 14, 2021

At Asphalion we are looking for new opportunities to collaborate in the currently open Horizon Europe calls with deadline on the 1st of February, 2022. Due to our expertise and extensive knowledge in the regulatory field for innovative therapies and medical device development, Asphalion can provide with a sound value to Consortia planning to apply for the following topics:

  • HORIZON-HLTH-2022-DISEASE-06-02-two-stage: “Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs”
  • HORIZON-HLTH-2022-DISEASE-06-04-two-stage: “Development of new effective therapies for rare diseases”
  • HORIZON-HLTH-2022-DISEASE-06-03-two-stage: “Vaccines 2.0 – developing the next generation of vaccines”
  • HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage: “Prevention of obesity throughout the life course”
  • HORIZON-HLTH-2022-STAYHLTH-01-04-two-stage: “Trustworthy artificial intelligence (AI) tools to predict the risk of chronic non-communicable diseases and/or their progression”

We would like to highlight that some of the above-mentioned topics require some sort of regulatory engagement with regulators and that we are experts in this area. In addition, we have an extensive experience in European projects (H2020), as we are involved in 15 different EU-funded projects as regulatory expert partner.

Either if you are planning to apply and you want to add a regulatory partner to your project, or you are interested in knowing more about Asphalion and our expertise, do not hesitate to contact us at: horizon@asphalion.com

 

 

 

Search News & Events

  • Filter by category

Share

Related news and events

In2Sight | 4th annual meeting 3RS congress

At ASPHALION, we are part of the IN2SIGHT consortium, an EU-funded project, and we are delighted to be currently participating in the 4th annual meeting

Course | Regulatory aspects of vaccine development

TRANSVAC2 supported innovation for both prophylactic and therapeutic vaccine development by providing high-quality technical services across four different service platforms: Technology (for process development and GMP production), Immunocorrelates & Systems Biology, Animal models, and support for Clinical Trials. TRANSVAC also offered training courses to provide fundamental and advanced knowledge on a wide-range of vaccine development-related topics.

ASPHALION HIGHLIGHTS Q2 2023

A lot of things have happened during these past three months. We received an award from AEFI as most engaged Company with its employees’ traning;

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting